COVID-19 Clinical Research Studies
COVID-19 Clinical Research Studies is a research topic within Infectious Diseases. Science Explorer counts 51k research works in it since 1950. 18.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the clinical characteristics, epidemiology, immune response, and treatment of Coronavirus Disease 2019 (COVID-19), caused by the SARS-CoV-2 virus. It covers topics such as thrombosis, ACE2 receptor, cytokine storm, and the pandemic's impact on various populations.
- Clinical Characteristics
- SARS-CoV-2
- Epidemiology
- Thrombosis
- Immune Response
- ACE2 Receptor
- Cytokine Storm
- Antiviral Treatment
- Pathophysiology
- Pandemic
- Research works
- 51k fractional, since 1950
- In the world top 10%
- 9.6k per year above
- Top-10% rate
- 18.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +5467% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead COVID-19 Clinical Research Studies research?
By volume, the United States and China publish the most (4k and 1.8k works in 2022–2025).
By volume, 2022–2025
- 1 United States 4k works
- 2 China 1.8k works
- 3 India 1.8k works
- 4 Italy 1k works
- 5 Iran 889 works
- 6 United Kingdom 848 works
- 7 Brazil 847 works
- 8 Türkiye 847 works
- 9 Spain 766 works
- 10 Russia 654 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead COVID-19 Clinical Research Studies research?
By volume in 2022–2025, University of North Carolina at Chapel Hill publishes the most COVID-19 Clinical Research Studies research, followed by Sağlık Bilimleri Üniversitesi and Tehran University of Medical Sciences.
By volume, 2022–2025
- 1 University of North Carolina at Chapel Hill United States 120 works
- 2 Sağlık Bilimleri Üniversitesi Türkiye 93 works
- 3 Tehran University of Medical Sciences Iran 70 works
- 4 All India Institute of Medical Sciences India 66 works
- 5 Ain Shams University Egypt 65 works
- 6 Shahid Beheshti University of Medical Sciences Iran 58 works
- 7 Harvard University United States 55 works
- 8 Chinese Academy of Medical Sciences & Peking Union Medical College China 49 works
- 9 Istituti di Ricovero e Cura a Carattere Scientifico Italy 49 works
- 10 Airlangga University Indonesia 48 works
Who are the leading researchers in COVID-19 Clinical Research Studies?
The most-cited researchers publishing on COVID-19 Clinical Research Studies include Giuseppe Remuzzi, John P. A. Ioannidis and Nelson Alvis‐Guzmán.
- 1 Giuseppe Remuzzi 8.1k citations
- 2 John P. A. Ioannidis 8k citations
- 3 Nelson Alvis‐Guzmán 7.7k citations
- 4 Alberto Ortíz 5.9k citations
- 5 Aziz Sheikh 5.8k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is COVID-19 Clinical Research Studies research done?
The largest centres of COVID-19 Clinical Research Studies research in 2022–2025 are Tehran (Iran), Beijing (China), London (United Kingdom) and Moscow (Russia).
Largest cities, 2022–2025
Where is the best place to study COVID-19 Clinical Research Studies?
Among universities, judged by research, London School of Hygiene & Tropical Medicine, Weill Cornell Medical College in Qatar and Victor Babeș University of Medicine and Pharmacy Timișoara score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | London School of Hygiene & Tropical Medicine United Kingdom | 56.1 | 39.8% | 5.1× | 17 | — |
| 2 | Weill Cornell Medical College in Qatar Qatar | 55.5 | 28.5% | 13.0× | 10 | — |
| 3 | Victor Babeș University of Medicine and Pharmacy Timișoara Romania | 53.1 | 22.7% | 10.8× | 22 | — |
| 4 | Tehran University of Medical Sciences Iran | 50.0 | 14.3% | 6.9× | 70 | — |
| 5 | Albert Einstein College of Medicine United States | 47.7 | 35.5% | 4.6× | 19 | — |
| 6 | University of Hong Kong Hong Kong | 47.5 | 34.9% | 1.9× | 36 | +3.8% |
| 7 | Sağlık Bilimleri Üniversitesi Türkiye | 47.1 | 2.9% | 7.5× | 93 | — |
| 8 | All India Institute of Medical Sciences India | 47.0 | 6.1% | 5.0× | 66 | +145.5% |
| 9 | Shahid Beheshti University of Medical Sciences Iran | 45.6 | 7.9% | 7.5× | 58 | — |
| 10 | University of Oxford United Kingdom | 45.4 | 35.2% | 1.2× | 34 | — |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is COVID-19 Clinical Research Studies research growing?
Output in 2018–2022 was 5467% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are COVID-19 Clinical Research Studies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.